SCHEMBL596755

SCHEMBL596755

C[N]CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11717074 0.67
SCHEMBL313188 0.67
Alcohol SCHEMBL28551069 0.63
SCHEMBL29587059 0.59
Alcohol SCHEMBL3924490 0.59
Ethylene Glycol SCHEMBL28494266 0.59
Methyl Alcohol SCHEMBL8575320 0.59
SCHEMBL589778 0.59
SCHEMBL8317224 0.59
Alcohol SCHEMBL28488370 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324257-B2 Mitotic kinesin inhibitors and methods of use thereof ARRAY BIOPHARMA INC. (US) 2012-12-04 US claimed
US-20100041719-A1 MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2010-02-18 US claimed
CN-101553476-A Mitotic kinesin inhibitors and methods of use thereof ARRAY BIOPHARMA INC (US) 2009-10-07 CN claimed
US-20230263803-A1 METHODS OF PREVENTING OR TREATING COVID-19 AND RELATED VIRAL DISEASES OR DISORDERS KINARUS AG (CH) 2023-08-24 US disclosed
EP-4196120-A1 METHODS OF PREVENTING OR TREATING COVID-19 AND RELATED VIRAL DISEASES OR DISORDERS Kinarus AG (CH) 2023-06-21 EP disclosed
EP-4159212-A1 P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD Fulcrum Therapeutics, Inc. (US) 2023-04-05 EP disclosed
US-11576916-B2 Methods of preventing or treating ophthalmic diseases KINARUS AG (CH) 2023-02-14 US disclosed
US-20220175786-A1 PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER SUPPORT-VENTURE GMBH (CH) 2022-06-09 US disclosed
US-20220133704-A1 P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD FULCRUM THERAPEUTICS INC (US) 2022-05-05 US disclosed
US-11291659-B2 P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Fulcrum Therapeutics, Inc. (US) 2022-04-05 US disclosed
WO-2022034031-A1 METHODS OF PREVENTING OR TREATING COVID-19 AND RELATED VIRAL DISEASES OR DISORDERS KINARUS AG (CH) 2022-02-17 WO disclosed
US-5011623-A Nonlinear optical material and nonlinear optical device CANON KABUSHIKI KAISHA (JP) 1991-04-30 US disclosed
US-4981614-A COMPRISING A MIXTURE OF POLYLACTONE OR NYLON COPOLYMER AND AN ORGANIC GUEST ELECTRONEGATIVE COMPOUND; NONLINEAR OPTICAL DEVICES; FILMS FOR DISPLAYS; CRYSTAL WAVELENGTH CONVERTERS FOR LASERS CANON KABUSHIKI KAISHA (JP) 1991-01-01 US disclosed
US-4946261-A Recording method and recording apparatus CANON KABUSHIKI KAISHA (JP) 1990-08-07 US disclosed
EP-0351832-A2 Nonlinear optical material and nonlinear optical device CANON KABUSHIKI KAISHA (JP) 1990-01-24 EP disclosed
EP-0332455-A2 Photosensitive material and image forming method CANON KABUSHIKI KAISHA (JP) 1989-09-13 EP disclosed
EP-0308852-A2 Solid solution CANON KABUSHIKI KAISHA (JP) 1989-03-29 EP disclosed
EP-0295145-A2 Recording method and recording apparatus CANON KABUSHIKI KAISHA (JP) 1988-12-14 EP disclosed
EP-0284229-A1 Nonlinear optical material and method for orientation thereof CANON KABUSHIKI KAISHA (JP) 1988-09-28 EP disclosed
US-4216111-A Stable dispersions of fluorescent whitening agents of the bis-triazinylaminostilbene group in free acid form and method of preparing same HICKSON & WELCH LIMITED (GB) 1980-08-05 US disclosed